The American Heart Association and Stroke Guidelines also found a high hospital mortality of 27% for patients with spontaneous intracerebral hemorrhage in the presence of FXa inhibitors, with mortality ratios significantly higher in patients taking FXa inhibitors than in patients not taking anticoagulants, but significantly lower than in patients taking warfarin, suggesting that anticoagulants with different mechanisms of action may have different prognoses for the same outcome [7]. This evidence concerns the gene F10 and stroke disorder.